| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |